SYNTHOS RESEARCH

Synthos Research · Health & longevity · all questions · the Conviction Board

How do I invest in longevity?

The most honest answer on this page: the science is rated 87/100 by our panel (568 claims — the deepest health cluster we track), but there is no clean public-market vehicle yet. It leads our 'frontier with no vehicle' list. Adjacent exposure today: GLP-1 franchises (Gap +21), biotech platforms, and diagnostics — when a pure vehicle appears, the Gap will be born wide.

Synthos Score (parent prediction): 87/100 · graded in public

Synthos Research · synthosresearch.com · as of July 6, 2026 · distilled from 53,000+ dated, attributed expert claims, weighted by verified track record · updated weekly

Want the full picture? The complete call — the dialectic, what would change our mind, and the live change-log — is on the prediction page. Track it and we'll email you the moment it moves.

Related questions

What do longevity scientists actually agree on?Are GLP-1 stocks still a buy?Is the GLP-1 hype justified by the science?Will AI transform drug discovery?